young-women-hand-scratch-the-itch-on-the-arm-healthcare-and-medicine young-women-hand-scratch-the-itch-on-the-arm-healthcare-and-medicine

P&T Atopic Dermatitis

Syndicated P&T Session: Atopic Dermatitis

MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

Learn how you can use P&T Perspectives to:

  • Gain an understanding of the impact of these agents in atopic dermatitis and how that might impact your brand
  • Boost your brand by identifying the key differentiators and any unforeseen access barriers
  • And more

Interested in obtaining the full video and learning more about how you can take advantage of P&T Perspectives?

Witness the Actual Discussions: